Search filters

List of works by Odd Erik Johansen

Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation

scholarly article by Satish Arora et al published 9 March 2019 in Cardiovascular Diabetology

Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease

scientific article published in January 2018

Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial

scientific article published on 09 February 2020

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>

scientific article published on 01 November 2020

Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial

scientific article published on 12 November 2020

Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events

scientific article published on 21 May 2015

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme ⬇️

scientific article published on January 10, 2012

Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia

scientific article published on 08 April 2009

Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study

scientific article

Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study.

scientific article

Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review

scientific article published on January 2007

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

scientific article

Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus ⬇️

scientific article published on September 15, 2010

Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial

scientific article published on 2 June 2009

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes

scientific article

Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

scientific article published on 09 August 2019

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

scientific article published on 22 May 2020

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

scientific article published on 28 August 2017

Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial

scientific article published on 17 May 2007

Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care

scientific article

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis

scientific article

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

scientific article

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

scientific article published on 14 June 2016

Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.

scientific article

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

scientific article published on March 2016

Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes

scientific article published on 20 October 2020

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article

Exenatide may aggravate moderate diabetic renal impairment: a case report

scientific article published on 15 May 2008

FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later

scientific article published on 12 March 2019

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

scientific article published on 14 December 2011

Glitazone treatment of type 2 diabetes mellitus

scientific article published in August 2006

HbA1c, Insulin Resistance, and β-Cell Function in Relation to Cognitive Function in Type 2 Diabetes: The CAROLINA Cognition Substudy.

scientific article

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

scientific article

Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes

scientific article published on 25 May 2007

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 4 December 2017

Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls

scientific article published on 28 October 2014

Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication

scientific article published on 10 October 2016

Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension

scientific article

Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects

scientific article

Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study

scientific article published on 30 August 2013

Interpretation of cardiovascular outcome trials in type 2 diabetes needs a multiaxial approach

scientific article

Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death

scientific article published on January 2017

Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes--a cross-sectional study

scientific article published on 14 November 2015

Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants

scientific article published on 23 March 2018

Misleading about insulin administration to patients with diabetes

scientific article published in August 2005

Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: the randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study

scientific article published on 9 June 2014

Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin

scientific article published on 28 August 2017

Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension

scientific article

Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects

scientific article published on 28 September 2008

Preventing macrovascular disease in patients with type 2 diabetes mellitus

scientific article (publication date: 2003)

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus

scientific article published on 15 January 2018

Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.

scientific article published on June 2008

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

scientific article

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus

scientific article published on 13 December 2013

SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials

scientific article

SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA.

scientific article published on 30 April 2019

Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies

scientific article published on 8 July 2014

Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials

scientific article published on 16 June 2016

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus

scientific article published on 29 January 2014

The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.

scientific article

Undiagnosed dysglycaemia and inflammation in cardiovascular disease

scientific article published in August 2006

Paulina is supported by:

About Paulina

Help